Acadia Pharmaceuticals (ACAD) Enterprise Value (2010 - 2026)
Acadia Pharmaceuticals' quarterly Enterprise Value came in at -$851.5 million in Q1 2026, down 24.92% year-on-year from -$1.1 billion in Q1 2025, and down 3.88% quarter-over-quarter from -$819.7 million in Q4 2025.
Acadia Pharmaceuticals has reported Enterprise Value for 17 years, with the latest figure at -$851.5 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 24.92% year-over-year to -$851.5 million; the trailing twelve-month figure through Mar 2026 stood at -$851.5 million (down 24.92% YoY), and the FY2025 full-year result was -$819.7 million, down 8.43% from the prior year.
- Enterprise Value for Q1 2026 stood at -$851.5 million, down from -$819.7 million in the prior quarter.
- The five-year high for Enterprise Value was -$345.9 million in Q3 2023, with the low at -$851.5 million in Q1 2026.
- Average Enterprise Value over 5 years is -$562.0 million, with a median of -$470.5 million recorded in 2024.
- Year-over-year, Enterprise Value advanced 22.81% in 2022 and tumbled 72.26% in 2024.
- Tracing ACAD's Enterprise Value over 5 years: stood at -$416.8 million in 2022, then slipped by 5.29% to -$438.9 million in 2023, then slumped by 72.26% to -$756.0 million in 2024, then declined by 8.43% to -$819.7 million in 2025, then dropped by 3.88% to -$851.5 million in 2026.
- The last three Enterprise Value figures came in at -$851.5 million (Q1 2026), -$819.7 million (Q4 2025), and -$847.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn | -851.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -851.46 Mn |
| Dec 31, 2025 | -819.69 Mn |
| Sep 30, 2025 | -847.02 Mn |
| Jun 30, 2025 | -762.00 Mn |
| Mar 31, 2025 | -681.58 Mn |
| Dec 31, 2024 | -755.99 Mn |
| Sep 30, 2024 | -565.33 Mn |
| Jun 30, 2024 | -500.94 Mn |
| Mar 31, 2024 | -470.52 Mn |
| Dec 31, 2023 | -438.87 Mn |
| Sep 30, 2023 | -345.92 Mn |
| Jun 30, 2023 | -375.38 Mn |
| Mar 31, 2023 | -402.87 Mn |
| Dec 31, 2022 | -416.82 Mn |
| Sep 30, 2022 | -436.58 Mn |
| Jun 30, 2022 | -436.35 Mn |
| Mar 31, 2022 | -445.98 Mn |
| Dec 31, 2021 | -520.71 Mn |
| Sep 30, 2021 | -540.29 Mn |
| Jun 30, 2021 | -556.92 Mn |
| Mar 31, 2021 | -577.77 Mn |
| Dec 31, 2020 | -631.96 Mn |
| Sep 30, 2020 | -644.44 Mn |
| Jun 30, 2020 | -658.55 Mn |
| Mar 31, 2020 | -651.41 Mn |
| Dec 31, 2019 | -697.43 Mn |
| Sep 30, 2019 | -683.85 Mn |
| Jun 30, 2019 | -381.89 Mn |
| Mar 31, 2019 | -414.32 Mn |
| Dec 31, 2018 | -473.52 Mn |
| Sep 30, 2018 | -214.14 Mn |
| Jun 30, 2018 | -256.86 Mn |
| Mar 31, 2018 | -298.06 Mn |
| Dec 31, 2017 | -341.34 Mn |
| Sep 30, 2017 | -366.63 Mn |
| Jun 30, 2017 | -417.32 Mn |
| Mar 31, 2017 | -469.48 Mn |
| Dec 31, 2016 | -529.04 Mn |
| Sep 30, 2016 | -588.86 Mn |
| Jun 30, 2016 | -412.56 Mn |
| Mar 31, 2016 | -457.24 Mn |
| Dec 31, 2015 | -215.13 Mn |
| Sep 30, 2015 | -240.69 Mn |
| Jun 30, 2015 | -270.78 Mn |
| Mar 31, 2015 | -297.89 Mn |
| Dec 31, 2014 | -322.49 Mn |
| Sep 30, 2014 | -337.80 Mn |
| Jun 30, 2014 | -354.45 Mn |
| Mar 31, 2014 | -369.29 Mn |
| Dec 31, 2013 | -185.79 Mn |
| Sep 30, 2013 | -185.52 Mn |
| Jun 30, 2013 | -187.79 Mn |
| Mar 31, 2013 | -83.81 Mn |
| Dec 31, 2012 | -90.31 Mn |
| Sep 30, 2012 | -23.06 Mn |
| Jun 30, 2012 | -21.35 Mn |
| Mar 31, 2012 | -25.92 Mn |
| Dec 31, 2011 | -31.05 Mn |
| Sep 30, 2011 | -36.15 Mn |
| Jun 30, 2011 | -40.36 Mn |
| Mar 31, 2011 | -6.83 Mn |
| Dec 31, 2010 | -37.09 Mn |
| Sep 30, 2010 | -9.66 Mn |